zoledronic acid has been researched along with interleukin-8 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bochicchio, AM; Budillon, A; Caraglia, M; Catalano, A; Facchini, G; Ferrari, E; Gentilini, D; Iaffaioli, RV; Leopardo, D; Marra, L; Marra, M; Morabito, A; Nasti, G; Perrone, F; Piccirillo, MC; Striano, S; Tortoriello, A; Vitale, G | 1 |
| Dirks, I; Jacobs, C; Meila, D; Pabst, A; Schramm, S; Walter, C; Wehrbein, H | 1 |
| Dell'Endice, S; Göbel, A; Jaschke, N; Kuhlmann, JD; Rachner, TD; Wimberger, P; Zinna, VM | 1 |
1 trial(s) available for zoledronic acid and interleukin-8
| Article | Year |
|---|---|
Metronomic administration of zoledronic acid and taxotere combination in castration resistant prostate cancer patients: phase I ZANTE trial.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Diphosphonates; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Feasibility Studies; Fever; Humans; Imidazoles; Infusions, Intravenous; Interleukin-8; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Middle Aged; Neutropenia; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Taxoids; Treatment Outcome; Zoledronic Acid | 2010 |
2 other study(ies) available for zoledronic acid and interleukin-8
| Article | Year |
|---|---|
Mechanical loading increases pro-inflammatory effects of nitrogen-containing bisphosphonate in human periodontal fibroblasts.
Topics: Biomarkers; Cells, Cultured; Clodronic Acid; Cyclooxygenase 2; Dinoprostone; Diphosphonates; Enzyme-Linked Immunosorbent Assay; Fibroblasts; Gene Expression; Humans; Imidazoles; Interleukin-8; Matrix Metalloproteinase 8; Periodontal Ligament; Real-Time Polymerase Chain Reaction; Stress, Mechanical; Tensile Strength; Tissue Inhibitor of Metalloproteinase-1; Zoledronic Acid | 2018 |
Anti-tumor effects of mevalonate pathway inhibition in ovarian cancer.
Topics: Apoptosis; Atorvastatin; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Female; Gene Expression; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-6; Interleukin-8; Mevalonic Acid; Ovarian Neoplasms; Polyisoprenyl Phosphates; Prenylation; Rosuvastatin Calcium; Sesquiterpenes; Simvastatin; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A; Zoledronic Acid | 2020 |